Author:
Heidenreich Axel,Bastian Patrick J.,Bellmunt Joaquim,Bolla Michel,Joniau Steven,van der Kwast Theodor,Mason Malcolm,Matveev Vsevolod,Wiegel Thomas,Zattoni Filiberto,Mottet Nicolas
Reference89 articles.
1. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer;Mottet;Eur Urol,2011
2. Oxford Centre for Evidence-Based Medicine Levels of Evidence (May 2009). Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. Updated by Jeremy Howick March 2009. http://www.cebm.net/index.aspx?o=1025.
3. Hormonal therapy: historical perspective to future directions;McLeod;Urology,2003
4. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis;Seidenfeld;Ann Intern Med,2000
5. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer;Klotz;BJU Int,2008
Cited by
1159 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献